Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 Characteristics of intraoperative cardiopulmonary bypass and operative characteristics of the patients

From: The cardioprotective effects of HTK solution and conventional blood cardioplegia in patients with atrial fibrillation undergoing valvular replacement and Cox maze III procedure

Cox-maze III combined valve surgery - no

HTK (n = 53)

BC (n = 53)

P

MVR

19(35.80)

24(45.30)

 

MVR plus AVR

5(9.40)

14(26.40)

 

MVR plus AVR plus TVr

4(7.50)

5(9.40)

 

MVr

4(7.50)

1(1.90)

 

TVr

0(0.00)

1(1.90)

 

MVr plus TVr

10(18.90)

3(5.70)

 

MVr plus TVr plus PDA

1(1.90)

0(00)

 

MVR plus AVR plus TVr plus ASDr

1(1.90)

0(0.00)

 

MVr plus TVr plus VSDr

1(1.90)

0(0.00)

 

MVr plus AVr plus TVr

1(1.90)

0(0.00)

 

MVr plus TVr plus ASDr

3(5.70)

0(0.00)

 

AVR plus MVr plus TVr

1(1.90)

0(0.00)

 

TVr plus ASDr

2(3.80)

0(0.00)

 

MVR plus AVr plus TVr

1(1.90)

5(9.4.0)

 

CPB time(min)

177.00 ± 26.69

174.66 ± 36.46

0.71

Aortic cross-clamp time(min)

124.68 ± 20.09

116.02 ± 24.54

0.05

Perfusion dose(ml)

2141.51 ± 247.60

3991.89 ± 983.80

<0.001

Number of doses of cardioplegia Perfusion times

1.21 ± 0.41

5.55 ± 1.14

<0.001

  1. Data is displayed as numbers (%) or as the mean ± standard deviation. Valve replacement for MVR, Mitral valve repair for MVr, Aortic valve replacement for AVR, Tricuspid valve repair for TVr, Aortic valve repair for AVr, Atrial Septal Defect repair for ASDr, Ventricular Septal Defect repair for VSDr, and Patent Ductus Arteriosus repair for PDA.CPB Cardiopulmonary